Antiparasitic Drugs Market by Product Type and Application- Global Industry Analysis & Forecast to 2027
Published On : January 2021 Pages : 158 Category: Pharma & Healthcare Report Code : HC0114663
Antiparasitic Drugs Market By Product Type (Anthelmintics, Antiprotozoals, Others), Delivery Type (Oral, Injectable, Topical) andApplication (Hospital, Clinic, Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Antiparasitic Drugs Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Antiparasitics are a class of medications which are indicated for the treatment of parasitic diseases, such as those caused by helminths, amoeba, ectoparasites, parasitic fungi, and protozoa, among others.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Antiparasitic Drugs Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Ipca Laboratories Ltd
- ZydusCadila
- Merck
- Pfizer
- GlaxoSmithKline Plc.
- Cipla Ltd
- Ranbaxy Laboratories
- Novartis AG
- Alvizia Health Care
- Bayer AG
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Antiparasitic Drugs Market, ByProduct Type, Estimates and Forecast, 2017-2027 ($Million)
o Anthelmintics
o Antiprotozoals
o Others
· Antiparasitic Drugs Market, ByDelivery Type, Estimates and Forecast, 2017-2027 ($Million)
o Oral
o Injectable
o Topical
· Antiparasitic Drugs Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Hospital
o Clinic
o Others
· Antiparasitic Drugs Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Ipca Laboratories Ltd
o ZydusCadila
o Merck
o Pfizer
o GlaxoSmithKline Plc.
o Cipla Ltd
o Ranbaxy Laboratories
o Novartis AG
o Alvizia Health Care
· Antiparasitic Drugs Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Antiparasitic Drugs Market, By Country
o U.S. Antiparasitic Drugs Market
o Canada Antiparasitic Drugs Market
o Mexico Antiparasitic Drugs Market
o Europe
§ Europe Antiparasitic Drugs Market, By Country
· Germany Antiparasitic Drugs Market
o UK Antiparasitic Drugs Market
o France Antiparasitic Drugs Market
o RussiaAntiparasitic Drugs Market
o Italy Antiparasitic Drugs Market
o Rest of Europe Antiparasitic Drugs Market
o Asia-Pacific
§ Asia-Pacific Antiparasitic Drugs Market, By Country
o ChinaAntiparasitic Drugs Market
o Japan Antiparasitic Drugs Market
o South KoreaAntiparasitic Drugs Market
o India Antiparasitic Drugs Market
o Southeast AsiaAntiparasitic Drugs Market
o Rest of Asia-Pacific Antiparasitic Drugs Market
o South America
§ South AmericaAntiparasitic Drugs Market
o Brazil Antiparasitic Drugs Market
o ArgentinaAntiparasitic Drugs Market
o ColumbiaAntiparasitic Drugs Market
o Rest of South America Antiparasitic Drugs Market
o Middle East and Africa
§ Middle East and AfricaAntiparasitic Drugs Market
o Saudi ArabiaAntiparasitic Drugs Market
o UAEAntiparasitic Drugs Market
o EgyptAntiparasitic Drugs Market
o NigeriaAntiparasitic Drugs Market
o South Africa Antiparasitic Drugs Market
o Rest of MEA Antiparasitic Drugs Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Antiparasitic Drugs Market, By Product Type
5.1. Introduction
5.2. Global Antiparasitic Drugs Revenue and Market Share by Product Type (2017-2021)
5.2.1. Global Antiparasitic Drugs Revenue and Revenue Share by Product Type (2017-2021)
5.3. Anthelmintics
5.3.1. Global Anthelmintics Revenue and Growth Rate (2017-2021)
5.4. Antiprotozoals
5.4.1. Global Antiprotozoals Revenue and Growth Rate (2017-2021)
5.5. Others
5.5.1. Global Others Revenue and Growth Rate (2017-2021)
6. Antiparasitic Drugs Market, By Delivery Type
6.1. Introduction
6.2. Global Antiparasitic Drugs Revenue and Market Share by Delivery Type (2017-2021)
6.2.1. Global Antiparasitic Drugs Revenue and Revenue Share by Delivery Type (2017-2021)
6.3. Oral
6.3.1. Global Oral Revenue and Growth Rate (2017-2021)
6.4. Injectable
6.4.1. Global Injectable Revenue and Growth Rate (2017-2021)
6.5. Topical
6.5.1. Global Topical Revenue and Growth Rate (2017-2021)
7. Antiparasitic Drugs Market, By End User
7.1. Introduction
7.2. Global Antiparasitic Drugs Revenue and Market Share by End User (2017-2021)
7.2.1. Global Antiparasitic Drugs Revenue and Revenue Share by End User (2017-2021)
7.3. Hospital
7.3.1. Global Hospital Revenue and Growth Rate (2017-2021)
7.4. Clinic
7.4.1. Global Clinic Revenue and Growth Rate (2017-2021)
7.5. Others
7.5.1. Global Others Revenue and Growth Rate (2017-2021)
8. Antiparasitic Drugs Market, By Region
8.1. Introduction
8.2. Global Antiparasitic Drugs Revenue and Market Share by Regions
8.2.1. Global Antiparasitic Drugs Revenue by Regions (2017-2021)
8.3. North America Antiparasitic Drugs by Countries
8.3.1. North America Antiparasitic Drugs Revenue and Growth Rate (2017-2021)
8.3.2. North America Antiparasitic Drugs Revenue (Million USD) by Countries (2017-2021)
8.3.3. United States
8.3.3.1. United States Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.3.4. Canada
8.3.4.1. Canada Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.3.5. Mexico
8.3.5.1. Mexico Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.4. Europe Antiparasitic Drugs by Countries
8.4.1. Europe Antiparasitic Drugs Revenue and Growth Rate (2017-2021)
8.4.2. Europe Antiparasitic Drugs Revenue (Million USD) by Countries (2017-2021)
8.4.3. Germany
8.4.3.1. Germany Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.4. France
8.4.4.1. France Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.5. UK
8.4.5.1. UK Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.6. Russia
8.4.6.1. Russia Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.7. Italy
8.4.7.1. Italy Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.5. Asia-Pacific Antiparasitic Drugs by Countries
8.5.1. Asia-Pacific Antiparasitic Drugs Revenue and Growth Rate (2017-2021)
8.5.2. Asia-Pacific Antiparasitic Drugs Revenue (Million USD) by Countries (2017-2021)
8.5.3. China
8.5.3.1. China Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.4. Japan
8.5.4.1. Japan Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.5. Korea
8.5.5.1. Korea Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.6. India
8.5.6.1. India Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.6. South America Antiparasitic Drugs by Countries
8.6.1. South America Antiparasitic Drugs Revenue and Growth Rate (2017-2021)
8.6.2. South America Antiparasitic Drugs Revenue (Million USD) by Countries (2017-2021)
8.6.3. Brazil
8.6.3.1. Brazil Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.6.4. Argentina
8.6.4.1. Argentina Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.6.5. Columbia
8.6.5.1. Columbia Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.7. Middle East and Africa Antiparasitic Drugs by Countries
8.7.1. Middle East and Africa Antiparasitic Drugs Revenue and Growth Rate (2017-2021)
8.7.2. Middle East and Africa Antiparasitic Drugs Revenue (Million USD) by Countries (2017-2021)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.5. Egypt
8.7.5.1. Egypt Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.6. Nigeria
8.7.6.1. Nigeria Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.7. South Africa
8.7.7.1. South Africa Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.8. Turkey
8.7.8.1. Turkey Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
9. Company Profiles
9.1. Ipca Laboratories Ltd
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. Zydus Cadila
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Merck
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. Pfizer
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. GlaxoSmithKline Plc.
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Cipla Ltd
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Ranbaxy Laboratories
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Novartis AG
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. Alvizia Health Care
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Bayer AG
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
10. Antiparasitic Drugs Market Forecast (2022-2027)
10.1. Global Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2022-2027)
10.2. Antiparasitic Drugs Market Forecast by Regions (2022-2027)
10.2.1. North America Antiparasitic Drugs Market Forecast (2022-2027)
10.2.1.1. United States Antiparasitic Drugs Market Forecast (2022-2027)
10.2.1.2. Canada Antiparasitic Drugs Market Forecast (2022-2027)
10.2.1.3. Mexico Antiparasitic Drugs Market Forecast (2022-2027)
10.2.2. Europe Antiparasitic Drugs Market Forecast (2022-2027)
10.2.2.1. Germany Antiparasitic Drugs Market Forecast (2022-2027)
10.2.2.2. France Antiparasitic Drugs Market Forecast (2022-2027)
10.2.2.3. UK Antiparasitic Drugs Market Forecast (2022-2027)
10.2.2.4. Russia Antiparasitic Drugs Market Forecast (2022-2027)
10.2.2.5. Italy Antiparasitic Drugs Market Forecast (2022-2027)
10.2.2.6. Rest of Europe Antiparasitic Drugs Market Forecast (2022-2027)
10.2.3. Asia-Pacific Antiparasitic Drugs Market Forecast (2022-2027)
10.2.3.1. China Antiparasitic Drugs Market Forecast (2022-2027)
10.2.3.2. Japan Antiparasitic Drugs Market Forecast (2022-2027)
10.2.3.3. Korea Antiparasitic Drugs Market Forecast (2022-2027)
10.2.3.4. India Antiparasitic Drugs Market Forecast (2022-2027)
10.2.3.5. Southeast Asia Antiparasitic Drugs Market Forecast (2022-2027)
10.2.3.6. Rest of Asia-Pacific Antiparasitic Drugs Market Forecast (2022-2027)
10.2.4. South America Antiparasitic Drugs Market Forecast (2022-2027)
10.2.4.1. Brazil Antiparasitic Drugs Market Forecast (2022-2027)
10.2.4.2. Argentina Antiparasitic Drugs Market Forecast (2022-2027)
10.2.4.3. Columbia Antiparasitic Drugs Market Forecast (2022-2027)
10.2.4.4. Rest of South America Antiparasitic Drugs Market Forecast (2022-2027)
10.2.5. Middle East and Africa Antiparasitic Drugs Market Forecast (2022-2027)
10.2.5.1. Saudi Arabia Antiparasitic Drugs Market Forecast (2022-2027)
10.2.5.2. United Arab Emirates Antiparasitic Drugs Market Forecast (2022-2027)
10.2.5.3. Egypt Antiparasitic Drugs Market Forecast (2022-2027)
10.2.5.4. Nigeria Antiparasitic Drugs Market Forecast (2022-2027)
10.2.5.5. South Africa Antiparasitic Drugs Market Forecast (2022-2027)
10.2.5.6. Turkey Antiparasitic Drugs Market Forecast (2022-2027)
10.2.5.7. Rest of Middle East and Africa Antiparasitic Drugs Market Forecast (2022-2027)
10.3. Antiparasitic Drugs Market Forecast by Product Type (2022-2027)
10.3.1. Antiparasitic Drugs Forecast by Product Type (2022-2027)
10.3.2. Antiparasitic Drugs Market Share Forecast by Product Type (2022-2027)
10.4. Antiparasitic Drugs Market Forecast by Delivery Type (2022-2027)
10.4.1. Antiparasitic Drugs Forecast by Delivery Type (2022-2027)
10.4.2. Antiparasitic Drugs Market Share Forecast by Delivery Type (2022-2027)
10.5. Antiparasitic Drugs Market Forecast by End User (2022-2027)
10.5.1. Antiparasitic Drugs Forecast by End User (2022-2027)
10.5.2. Antiparasitic Drugs Market Share Forecast by End User (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Antiparasitic Drugs Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Anthelmintics Revenue and Growth Rate (2017-2019)
Figure Global Antiprotozoals Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Antiparasitic Drugs Revenue and Revenue Share by Delivery Type (2017-2019)
Figure Global Oral Revenue and Growth Rate (2017-2019)
Figure Global Injectable Revenue and Growth Rate (2017-2019)
Figure Global Topical Revenue and Growth Rate (2017-2019)
Table Global Antiparasitic Drugs Revenue and Revenue Share by End User (2017-2019)
Figure Global Hospital Revenue and Growth Rate (2017-2019)
Figure Global Clinic Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Antiparasitic Drugs Revenue by Regions (2017-2019)
Figure North America Antiparasitic Drugs Growth Rate (2017-2019)
Figure North America Antiparasitic Drugs Revenue and Growth Rate (2017-2019)
Figure North America Antiparasitic Drugs by Countries (2017-2019)
Figure North America Antiparasitic Drugs Revenue (Million USD) by Countries (2017-2019)
Figure United States Antiparasitic Drugs Growth Rate (2017-2019)
Figure United States Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Antiparasitic Drugs Growth Rate (2017-2019)
Figure Canada Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Antiparasitic Drugs Growth Rate (2017-2019)
Figure Mexico Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Antiparasitic Drugs Growth Rate (2017-2019)
Figure Europe Antiparasitic Drugs Revenue and Growth Rate (2017-2019)
Figure Europe Antiparasitic Drugs by Countries (2017-2019)
Figure Europe Antiparasitic Drugs Revenue (Million USD) by Countries (2017-2019)
Figure Germany Antiparasitic Drugs Growth Rate (2017-2019)
Figure Germany Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Antiparasitic Drugs Growth Rate (2017-2019)
Figure France Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Antiparasitic Drugs Growth Rate (2017-2019)
Figure UK Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Antiparasitic Drugs Growth Rate (2017-2019)
Figure Russia Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Antiparasitic Drugs Growth Rate (2017-2019)
Figure Italy Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Antiparasitic Drugs Growth Rate (2017-2019)
Figure Rest of Europe Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Antiparasitic Drugs Growth Rate (2017-2019)
Figure Asia-Pacific Antiparasitic Drugs Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Antiparasitic Drugs by Countries (2017-2019)
Figure Asia-Pacific Antiparasitic Drugs Revenue (Million USD) by Countries (2017-2019)
Figure China Antiparasitic Drugs Growth Rate (2017-2019)
Figure China Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Antiparasitic Drugs Growth Rate (2017-2019)
Figure Japan Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Antiparasitic Drugs Growth Rate (2017-2019)
Figure Korea Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Antiparasitic Drugs Growth Rate (2017-2019)
Figure India Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Antiparasitic Drugs Growth Rate (2017-2019)
Figure Southeast Asia Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Antiparasitic Drugs Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Antiparasitic Drugs Growth Rate (2017-2019)
Figure South America Antiparasitic Drugs Revenue and Growth Rate (2017-2019)
Figure South America Antiparasitic Drugs by Countries (2017-2019)
Figure South America Antiparasitic Drugs Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Antiparasitic Drugs Growth Rate (2017-2019)
Figure Brazil Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Antiparasitic Drugs Growth Rate (2017-2019)
Figure Argentina Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Antiparasitic Drugs Growth Rate (2017-2019)
Figure Columbia Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Antiparasitic Drugs Growth Rate (2017-2019)
Figure Rest of South America Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Antiparasitic Drugs Growth Rate (2017-2019)
Figure Middle East and Africa Antiparasitic Drugs Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Antiparasitic Drugs by Countries (2017-2019)
Figure Middle East and Africa Antiparasitic Drugs Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Antiparasitic Drugs Growth Rate (2017-2019)
Figure Saudi Arabia Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Antiparasitic Drugs Growth Rate (2017-2019)
Figure United Arab Emirates Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Antiparasitic Drugs Growth Rate (2017-2019)
Figure Egypt Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Antiparasitic Drugs Growth Rate (2017-2019)
Figure Nigeria Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Antiparasitic Drugs Growth Rate (2017-2019)
Figure South Africa Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Antiparasitic Drugs Growth Rate (2017-2019)
Figure Turkey Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Antiparasitic Drugs Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Table Ipca Laboratories Ltd Antiparasitic Drugs Financial Overview
Table Zydus Cadila Antiparasitic Drugs Financial Overview
Table Merck Antiparasitic Drugs Financial Overview
Table Pfizer Antiparasitic Drugs Financial Overview
Table GlaxoSmithKline Plc. Antiparasitic Drugs Financial Overview
Table Cipla Ltd Antiparasitic Drugs Financial Overview
Table Ranbaxy Laboratories Antiparasitic Drugs Financial Overview
Table Novartis AG Antiparasitic Drugs Financial Overview
Table Alvizia Health Care Antiparasitic Drugs Financial Overview
Table Bayer AG Antiparasitic Drugs Financial Overview
Figure Global Antiparasitic Drugs Revenue (Millions USD) and Growth Rate (2019-2027)
Table Antiparasitic Drugs Market Forecast by Regions (2019-2027)
Figure North America Antiparasitic Drugs Market Forecast (2019-2027)
Figure United States Antiparasitic Drugs Market Forecast (2019-2027)
Figure Canada Antiparasitic Drugs Market Forecast (2019-2027)
Figure Mexico Antiparasitic Drugs Market Forecast (2019-2027)
Figure Europe Antiparasitic Drugs Market Forecast (2019-2027)
Figure Germany Antiparasitic Drugs Market Forecast (2019-2027)
Figure France Antiparasitic Drugs Market Forecast (2019-2027)
Figure UK Antiparasitic Drugs Market Forecast (2019-2027)
Figure Russia Antiparasitic Drugs Market Forecast (2019-2027)
Figure Italy Antiparasitic Drugs Market Forecast (2019-2027)
Figure Rest of Europe Antiparasitic Drugs Market Forecast (2019-2027)
Figure Asia-Pacific Antiparasitic Drugs Market Forecast (2019-2027)
Figure China Antiparasitic Drugs Market Forecast (2019-2027)
Figure Japan Antiparasitic Drugs Market Forecast (2019-2027)
Figure Korea Antiparasitic Drugs Market Forecast (2019-2027)
Figure India Antiparasitic Drugs Market Forecast (2019-2027)
Figure Southeast Asia Antiparasitic Drugs Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Antiparasitic Drugs Market Forecast (2019-2027)
Figure South America Antiparasitic Drugs Market Forecast (2019-2027)
Figure Brazil Antiparasitic Drugs Market Forecast (2019-2027)
Figure Argentina Antiparasitic Drugs Market Forecast (2019-2027)
Figure Columbia Antiparasitic Drugs Market Forecast (2019-2027)
Figure Rest of South America Antiparasitic Drugs Market Forecast (2019-2027)
Figure Middle East and Africa Antiparasitic Drugs Market Forecast (2019-2027)
Figure Saudi Arabia Antiparasitic Drugs Market Forecast (2019-2027)
Figure United Arab Emirates Antiparasitic Drugs Market Forecast (2019-2027)
Figure Egypt Antiparasitic Drugs Market Forecast (2019-2027)
Figure Nigeria Antiparasitic Drugs Market Forecast (2019-2027)
Figure South Africa Antiparasitic Drugs Market Forecast (2019-2027)
Figure Turkey Antiparasitic Drugs Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Antiparasitic Drugs Market Forecast (2019-2027)
Figure Global Antiparasitic Drugs Forecast by Product Type (2019-2027)
Figure Global Antiparasitic Drugs Market Share Forecast by Product Type (2019-2027)
Figure Global Antiparasitic Drugs Forecast by Product Type (2019-2027)
Figure Global Antiparasitic Drugs Forecast by Delivery Type (2019-2027)
Figure Global Antiparasitic Drugs Market Share Forecast by Delivery Type (2019-2027)
Figure Global Antiparasitic Drugs Forecast by Delivery Type (2019-2027)
Figure Global Antiparasitic Drugs Forecast by End User (2019-2027)
Figure Global Antiparasitic Drugs Market Share Forecast by End User (2019-2027)
Figure Global Antiparasitic Drugs Forecast by End User (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|